Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
AngioScore
company
About
AngioScore develops scoring balloon catheters to treat cardiovascular and peripheral artery diseases.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $30M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 51 - 100
- Operating Status
- Active
AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$75M
AngioScore has raised a total of
$75M
in funding over 2 rounds. Their latest funding was raised on
Oct 9, 2007 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 9, 2007 | Series E | $30M | 1 | — | — | Detail |
| Apr 11, 2006 | Series D | $30M | 1 | — | — | Detail |
| Aug 23, 2004 | Series B | $15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
AngioScore is funded by 1 investors.
Innomed Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
